SJS / TEN 2023

Professor of Medicine, Dermatology, Pathology, Microbiology Professor of Pharmacology John A. Oates Chair in Clinical Research Center for Drug Safety and Immunology, Vanderbilt University Medical Center

Dr. Phillips is a world leader in translational approaches to drug hypersensitivity and has pioneered the discovery and implementation of immunogenomic predictors, immunopathogenesis and novel technologies to improve the safety of drugs into clinical practice. She has a clinical practice dedicated to drug hypersensitivity and has led clinical and research programs in SJS/TEN and other severe immune-mediated adverse drug reactions across different medical systems for over 25 years. She is PI on NIH funded research to define genetic and other markers to lead to prediction and prevention earlier diagnosis and to define the most effective treatment. She has been a great advocate of integration and engagement of the community in science. In addition to being a Chair of SJSTEN 2022 she also founded and chaired the 2017, 2019, and 2021 meetings, in addition to the DRESS 2022 virtual meeting.

Hajirah N. Saeed, MD, MPH; Associate Professor of Opthalmology, Illinois Eye and Ear, Univ. Illinois Chicago; Cliical Associate Professor (part-time), Loyola University Medical Center; Lecturer (part-time), Mass. Eye and Ear, Harvard Medical School

Dr. Saeed is an international expert on SJS/TEN, with a focus on ocular disease. She has standardized treatment for ocular disease in SJS/TEN and has pioneered novel treatments to make ocular care more accessible for patients. Her clinical practice is focused on providing expert care for patients with severe ocular surface disease from SJS/TEN and she promotes recognition of the impact this rare, but debilitating, disease has on a patient’s quality of life and public health. Dr. Saeed is also PI and a collaborator on several NIH-funded programs to study genetic risk factors in the development of SJS/TEN with and without ocular disease.

Robert Micheletti, MD is Associate Professor of Medicine and Dermatology at the Hospital of the University of Pennsylvania

He completed a combined residency in internal medicine and dermatology at the University of Pennsylvania, where he is now Associate Professor of Dermatology and Medicine. He is the Chief of Hospital Dermatology at Penn as well as Chief of Dermatology at Pennsylvania Hospital. He also directs the Cutaneous Vasculitis Clinic in the Penn Vasculitis Center. He has clinical and research focuses in vasculitis, severe drug reactions, autoimmune blistering diseases, hidradenitis suppurativa, and other areas of complex medical dermatology. He is the recipient of teaching awards from medical students and housestaff, and in 2019 he was elected to the Academy of Master Clinicians at Penn Medicine.